Skip to evidence report

FIB.adventitial.complement_angiocrine: Studies — page 5

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 5,164 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 4,001–5,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for FIB.adventitial.complement_angiocrine
#Trait / studyIndividual trait IDMean IC score
4001AREG levelsGCST904683470.87
4002CRELD2 levelsGCST904688590.87
4003aparc-a2009s lh volume G-cingul-Post-ventralGCST900029340.87
4004Posterior thigh muscle fat infiltration percentageGCST902673550.87
4005Transient global amnesiaFING000013740.86
4006Prevotella sp000434975 abundance in stoolGCST900325180.86
4007Alpha angleGCST901296350.86
4008Osteitis deformans and osteopathies associated with other disorders classified elsewhere (PheCode 731)GCST904762460.86
4009Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T280ECGU0002800.86
4010F-caffeinated/sweet liking (derived food-liking factor)GCST900947200.86
4011ALPP/MSLN ratioGCST903132500.86
4012aparc-a2009s rh area G-pariet-inf-AngularGCST900033950.86
4013T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 10)GCST903208290.86
4014SHBG levelsUKBB000007670.86
4015IDP T1 FAST ROIs L cerebellum VIGCST900025660.86
4016Triglyceride (52:5) levelsGCST904883200.86
4017aparc-a2009s lh area S-temporal-supGCST900033690.86
4018BA-exvivo rh thickness V2GCST900035370.86
4019Mean volume of bilateral amygdalaGCST904748990.86
4020aparc-a2009s lh area S-calcarineGCST900033400.86
4021PDGFC/TFPI ratioGCST903156360.85
4022DTI TBSS MD External capsule RGCST903846040.85
4023CASP1 levelsGCST904685430.85
4024FOLR1 levelsGCST904692590.85
4025PDCD5 levelsGCST904701820.85
4026APP/DAG1 ratioGCST903133200.85
4027Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T6ECGA0000060.85
4028Ganglion cell inner plexiform layer (GCIPL) thicknessGCST900142670.85
4029Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T173ECGU0001730.85
4030IDP dMRI TBSS L3 Body of corpus callosumGCST900041740.85
4031BCHE levelsGCST904684290.85
4032MFAP4 levelsGCST904698980.85
4033Family history of certain disabilities and chronic diseases leading to disablement | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000002360.85
4034IDP dMRI TBSS ICVF Pontine crossing tractGCST900043280.85
4035KLK11/KLK8 ratioGCST903152540.85
4036FSHB levelsGCST904692700.85
4037CA6 levelsGCST904685150.85
4038Lysophosphatidylcholine (26:0) [sn1] levelsGCST900254270.85
4039Treatment/medication code - lansoprazole | MedicationsUKBB000008480.84
4040Volume of right cortical nucleusGCST904750300.84
4041CNTN3 levelsGCST904688050.84
4042ENAH levelsGCST904691060.84
4043Fibroblastic disorders | Other soft tissue disordersUKBB000002460.84
4044Suppurative and unspecified otitis mediaFING000013460.84
4045ThalamNuclei lh volume CeMGCST900027250.84
4046CXCL5/MESD ratioGCST903143500.84
4047IGF2R/RNASET2 ratioGCST903151320.84
4048FAM171B levelsGCST900903390.84
4049Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T9ECGA0000090.84
4050BOLA2 or BOLA2B levelsGCST904684600.83
4051ICD10 N91.0, N91.1, N91.2: Amenorrhea, including primary amenorrhea, secondary amenorrhea and unspecified amenorrheaGCST904542190.83
4052Medication use (HMG CoA reductase inhibitors)GCST900187690.83
4053IDP dMRI ProbtrackX ICVF ptr lGCST900043940.83
4054Blood clot / pulmonary embolism / deep vein thrombosis (DVT)GCST904752090.83
4055IDP dMRI TBSS ICVF Posterior thalamic radiation RGCST900043550.83
4056Number of self-reported non-cancer illnesses | Medical conditionsUKBB000005410.83
4057Nonalcoholic fatty liver disease in overweight individuals (25<=BMI<=30)GCST902750470.83
4058PLA2G1B levelsGCST904702460.83
4059CD22/FCRL1 ratioGCST903137570.83
4060APRT/EREG ratioGCST903133350.83
4061HGF/PLAUR ratioGCST903150590.83
4062DDAH1 levelsGCST904689660.83
4063TPK1 levelsGCST904709430.83
4064MEGF9/OXT ratioGCST903154190.83
4065Left-hemisphere somatomotor network to left-hemisphere default mode network white-matter structural connectivityGCST903026740.83
4066T1 FreeSurfer DKT rh lingual areaGCST903842970.83
4067Polyp of the female genital tractFING000011900.83
4068Fracture of rib(s), sternum and thoracic spineFING000005580.83
4069ICD10 C53: Malignant neoplasm of cervix uteriGCST904542020.83
4070CELA2A levelsGCST904687010.82
4071IDP dMRI ProbtrackX ICVF slf lGCST900043960.82
4072Coffee difference likingGCST900947380.82
4073Coagulation defects (PheCode 286)GCST904757960.82
4074CRADD/EDAR ratioGCST903142350.82
4075aseg rh volume Cerebellum-CortexGCST900026360.82
4076Longitudinal peak diastolic strain rateGCST900190130.82
4077Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T158ECGU0001580.82
4078Left ventricular ejection fractionGCST902681250.82
4079IDP dMRI TBSS FA Cerebral peduncle RGCST900038910.82
4080JAM2/THBD ratioGCST903152390.82
4081aparc-a2009s lh area G-pariet-inf-SupramarGCST900033220.82
4082CDC27 levelsGCST904686640.82
4083Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T171ECGU0001710.82
4084Osteoporosis (PheCode 743.1)GCST904763840.82
4085IL6ST/PDGFRA ratioGCST903151690.82
4086Non-cancer illness code, self-reported - depression | Medical conditionsUKBB000005070.82
4087T1 FreeSurfer aseg Right-choroid-plexusGCST903841700.81
4088ATXN10/CASP10 ratioGCST903133960.81
4089Omega-3 fatty acids to total fatty acids percentageGCST905024500.81
4090Calculus of kidney and ureterFING000002360.81
4091Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T98ECGA0000980.81
4092Dysmenorrheic pain severityGCST0066560.81
4093Volume of right basal nucleusGCST904750150.81
4094Excessive sweatingGCST0060900.81
4095Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T119ECGA0001190.81
4096SLC27A4/TDRKH ratioGCST903158510.81
4097Takes medication for congestive heart failure?GCST904752010.81
4098Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T172ECGU0001720.81
4099Indolebutyrate levelsGCST901997590.81
4100Asphyxia and hypoxemia (PheCode 1013)GCST904755590.81
4101Pustulosis palmaris et plantarisFING000012330.81
4102Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T8ECGA0000080.81
4103HSPG2/VASN ratioGCST903150940.81
4104Enthesopathies of lower limb, excluding footFING000005090.81
4105aparc-a2009s rh volume G-pariet-inf-SupramarGCST900030240.81
4106Oily fish intake | DietUKBB000005470.81
4107Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T457ECGA0004570.80
4108PECAM1 levelsGCST904702060.80
4109Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T354ECGA0003540.80
4110IL31RA levelsGCST904695890.80
4111HippSubfield lh volume molecular-layer-HP-headGCST900026770.80
4112IDP T1 FIRST left putamen volumeGCST900024400.80
4113SOST/SPP1 ratioGCST903158710.80
4114DOK2 levelsGCST904690290.80
4115OsteoporosisGCST904681450.80
4116FABP5 levelsGCST904691770.80
4117DorsopathiesFING000004730.80
4118DTI TBSS L3 Splenium of corpus callosumGCST903845280.80
4119Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T358ECGA0003580.80
4120DTI TBSS FA Posterior corona radiata RGCST903844060.79
4121aparc-a2009s rh area G-oc-temp-lat-fusiforGCST900033910.79
4122Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T363ECGA0003630.79
4123Nasal polyps (PheCode 471)GCST904760190.79
4124DECR1/MAP2K6 ratioGCST903144470.79
4125eGFR in diabetes mellitus (loose) kidney healthy controls (minimal adjustment)GCST906247780.79
4126DPP4/ITGB1 ratioGCST903145400.79
4127T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109)GCST903206720.79
4128Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T177ECGU0001770.79
4129FOXO3/MAP3K5 ratioGCST903148800.79
4130NTRK2 levelsGCST904700970.78
4131L1CAM levelsGCST904697230.78
4132wg rh intensity-contrast entorhinalGCST900038320.78
4133MMP10 levelsGCST904699150.78
4134RBP5 levelsGCST904704390.78
4135T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117)GCST903206800.78
4136Placental weight (fetal genotype, adjusted for sex and gestational age)GCST902751890.78
4137DNAJC6 levelsGCST904690170.78
4138Pulmonary fibrosisGCST900186880.78
4139Principal component-derived dietary pattern 33GCST901330380.78
4140IL6 expression at 6 weeks in whole blood upon Bbmix moi30 stimulation in Lyme borreliosisGCST902757890.78
4141Other disorders of testis (PheCode 603)GCST904761560.78
4142DBN1 levelsGCST904689500.78
4143OsteoarthritisGCST901342880.78
4144DKK1/PDGFA ratioGCST903144750.78
4145ANG levelsGCST904683070.77
4146Shoulder lesions | Other soft tissue disordersUKBB000007690.77
4147Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T61ECGA0000610.77
4148LAT/LYN ratioGCST903152830.77
4149Left-hemisphere default mode network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027610.77
4150Diseases of arteries, arterioles and capillaries (FINNGEN)FING000004230.77
4151IDP dMRI TBSS ICVF Sagittal stratum LGCST900043580.77
4152OSMR levelsGCST904701320.77
4153Triacylglycerol_50:2_[M+NH4]1+ levelsGCST900604730.77
4154BCAN/CD200 ratioGCST903134770.77
4155Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T362ECGA0003620.77
4156MTDH levelsGCST904699540.77
4157Ovarian dysfunctionFING000011330.76
4158MCAM levelsGCST904698700.76
4159Principal component-derived dietary pattern 43GCST901330480.76
4160COLEC12 levelsGCST904688240.76
4161ATG16L1 levelsGCST904683830.76
4162DNM3 levelsGCST904690220.76
4163NCR3LG1 levelsGCST904700100.76
4164Leisure/social activities - Adult education class | Social supportUKBB000003980.76
4165Medication for pain relief, constipation, heartburn - None of the above | MedicationUKBB000004570.76
4166Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T170ECGU0001700.76
4167Triacylglycerol_52:3_[M+NH4]1+ levelsGCST900605090.76
4168DPP6/SEZ6L ratioGCST903145440.76
4169HGF/MMP8 ratioGCST903150550.76
4170OTUD7B levelsGCST904701370.76
4171SNX9/VASH1 ratioGCST903158660.76
4172Glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) levelsGCST902001050.76
4173PPP1R12A/TXNDC5 ratioGCST903157140.76
4174CD69/EDAR ratioGCST903138750.76
4175IDP dMRI TBSS MO Posterior limb of internal capsule RGCST900039700.75
4176Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T423ECGU0004230.75
4177Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T108ECGU0001080.75
4178Histidine levelsGCST902434040.75
4179PLXDC1 levelsGCST904702630.75
4180SEL1L levelsGCST904705640.75
4181Glycerate levelsGCST902002900.75
4182Myocardial fractal dimension (slice 4)GCST900002900.75
4183APP/NID2 ratioGCST903133270.75
4184Right-hemisphere control network to right-hemisphere control network white-matter structural connectivityGCST903028340.75
4185UBE2L6 levelsGCST904710010.75
4186HNRNPK levelsGCST904694690.75
4187CKAP4/LTBR ratioGCST903140740.75
4188low density lipoprotein cholesterol (LDLC, mean, inv-norm transformed)GCST904754160.75
4189F3 levelsGCST900120140.75
4190ADAMTS15 levelsGCST904682230.75
4191aparc-a2009s rh volume Pole-occipitalGCST900030400.75
4192Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T170ECGA0001700.75
4193PTPRN2/RTBDN ratioGCST903157540.74
4194ANGPT2 levelsGCST904683010.74
4195wg lh intensity-contrast fusiformGCST900037980.74
4196STXBP1 levelsGCST904707770.74
4197PBXIP1 levelsGCST904701640.74
4198ITGB1BP2/PTPN6 ratioGCST903152180.74
4199Urine taurocholenate sulfate* levels in chronic kidney diseaseGCST902660410.74
4200Bacterial pneumoniaeFING000001390.74
4201Emotional neglectGCST905518460.74
4202Maximum carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasoundUKBB000004290.74
4203SPOCK1 levelsGCST904707300.74
4204GIPC2 levelsGCST904693470.74
4205ECE1 levelsGCST904690610.74
4206PDGFA/SPARC ratioGCST903156200.74
4207Autoimmune polyglandular failureFING000001350.74
4208IDP dMRI TBSS FA Sagittal stratum LGCST900039080.73
4209rfMRI amplitudes (ICA100 node 45)GCST900046330.73
4210IDP dMRI ProbtrackX ICVF str rGCST900043990.73
4211Total protein levelsGCST900187560.73
4212CD300LG/CLEC14A ratioGCST903138010.73
4213FABP6 levelsGCST904691780.73
4214aparc-DKTatlas rh volume supramarginalGCST900029220.73
4215Diacylglycerol_36:3_[M+H-H2O]1+ levelsGCST900601890.73
4216Plasma sulfate of piperine metabolite C18H21NO3 (1)* levels in chronic kidney diseaseGCST902660160.73
4217BIRC2/CD40LG ratioGCST903135170.73
4218LAMA4 levelsGCST904697310.73
4219IDP dMRI TBSS ICVF Superior corona radiata RGCST900043510.73
4220Chronic rhinitis, nasopharyngitis and pharyngitisFING000002970.73
4221Horseradish likingGCST900947830.73
4222EGF/MGLL ratioGCST903146100.73
4223BA-exvivo rh volume BA1GCST900028490.72
4224LRP1 levelsGCST904697970.72
4225Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T63ECGA0000630.72
4226IDP T1 FAST ROIs L temporal poleGCST900024650.72
4227DBI/EDAR ratioGCST903144080.72
4228Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T124ECGA0001240.72
4229Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T464ECGU0004640.72
4230TNFRSF10A levelsGCST904708990.72
4231MESD levelsGCST904698910.72
4232IDP dMRI TBSS L2 Cingulum cingulate gyrus RGCST900041570.72
4233Left molecular layer hippocampal volume (body)GCST902679530.72
4234Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454)GCST902695510.72
4235SPINK1 levelsGCST904707210.72
4236ThalamNuclei rh volume MDlGCST900027480.72
4237COMMD1 levelsGCST904688250.72
4238IDP dMRI TBSS OD External capsule LGCST900044350.71
4239aparc-pial rh area superiorparietalGCST900032020.71
4240Uric acid levelsGCST902786460.71
4241Sphingomyelin_42:2_[M+H]1+ levelsGCST900604030.71
4242Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T117ECGA0001170.71
4243OGA levelsGCST904701170.71
4244Free testosterone levelsGCST902398260.70
4245BA-exvivo rh area BA4pGCST900032260.70
4246aparc-a2009s lh area G+S-subcentralGCST900033000.70
4247Bicarbonate (minimum, inv-norm transformed)GCST904751500.70
4248HSPB6 levelsGCST904694900.70
4249IDP dMRI TBSS L3 Superior cerebellar peduncle LGCST900041840.70
4250Cereal consumption (bowls per week) (UKB data field 1458)GCST901329820.70
4251Luteinizing hormone levelsGCST904834780.70
4252F8 levelsGCST902407250.70
4253Bursitis (PheCode 726.3)GCST904762400.70
4254aparc-Desikan rh area parsopercularisGCST900031240.70
4255PDGFB/PRKAR1A ratioGCST903156240.70
4256wg lh intensity-contrast middletemporalGCST900038060.70
4257BLVRB/CA1 ratioGCST903135210.70
4258IDP dMRI ProbtrackX FA slf rGCST900039470.70
4259HHIP levelsGCST906170970.70
4260Early age-related macular degenerationGCST0107230.70
4261OtosclerosisFING000011310.70
4262Wears glasses or contact lenses | EyesightUKBB000009070.70
4263Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T169ECGU0001690.69
4264IDP dMRI TBSS MD Anterior limb of internal capsule RGCST900040430.69
4265Nontoxic nodular goiter (PheCode 241)GCST904756380.69
4266VSTM2B levelsGCST904710560.69
4267B4GALT1/SMOC2 ratioGCST903134330.69
4268Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T359ECGA0003590.69
4269F3/GFRA1 ratioGCST903147410.69
4270aparc-DKTatlas rh area fusiformGCST900032700.69
4271BAG3 levelsGCST904684160.69
4272Omega-3 fatty acids to total fatty acids percentageGCST905020820.69
4273aparc-Desikan rh area fusiformGCST900031130.69
4274Plasma 3-hydroxybutyroylglycine** levels in chronic kidney diseaseGCST902644880.69
4275MPO levelsGCST904699370.68
4276Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T235ECGU0002350.68
4277PTPN1 levelsGCST904703760.68
4278REG4 levelsGCST904704510.68
4279Status post-amiFING000013330.68
4280AKT1S1 levelsGCST904682760.68
4281Patient classification on admission (recoded) - Day case | Summary AdministrationUKBB000006360.68
4282CACNA2D3 levelsGCST902433480.68
4283Depression or dysthymiaFING000004000.68
4284AMIGO2 levelsGCST904682920.68
4285GTPBP2 levelsGCST904694170.68
4286Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T438ECGU0004380.68
4287Retinal detachments and defects (PheCode 361)GCST904758450.68
4288VEGFD levelsGCST904710370.68
4289CNPY4/ERBIN ratioGCST903141480.68
4290Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T176ECGU0001760.67
4291NFATC1/TJAP1 ratioGCST903155400.67
4292ANP32B levelsGCST902401760.67
4293DTI autoptx MD cgc l tractGCST903852240.67
4294TAX1BP1 levelsGCST904708080.67
4295NCS1 levelsGCST904700110.67
4296Creatinine levelsGCST900259460.67
4297DTI TBSS L1 External capsule LGCST903844610.67
4298TGFBR2/THBD ratioGCST903159160.67
4299CD79B/TNFRSF13B ratioGCST903139020.67
4300DTI TBSS MD Cingulum cingulate gyrus RGCST903846060.66
4301DTI TBSS L3 Uncinate fasciculus RGCST903845680.66
4302IDP T1 FAST ROIs brain stemGCST900025610.66
4303HLA-DQA2 levelsGCST904270490.66
4304CDH15 levelsGCST904686680.66
4305IGFBP6/MFAP5 ratioGCST903151350.66
4306IDP dMRI TBSS L1 Anterior corona radiata LGCST900040980.66
4307Cholesteryl ester_14:0_[M+NH4]1+ levelsGCST900601970.66
4308CXCL16/NOTCH1 ratioGCST903143390.66
4309Average weekly beer plus cider intake | AlcoholUKBB000000820.66
4310Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T110ECGU0001100.66
4311CCL17/F2R ratioGCST903136860.66
4312Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T168ECGU0001680.66
4313Prescriptions - bisoprolol | selective beta1 antagonist,beta blockerUKBB000006720.66
4314DAB2/FKBP1B ratioGCST903143620.66
4315Premature beats (PheCode 427.6)GCST904759770.66
4316ChalazionFING000002670.66
4317Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T360ECGA0003600.66
4318aparc-DKTatlas lh volume postcentralGCST900028820.65
4319Parental longevity (father's age at death)GCST0067000.65
4320CHRDL2 levelsGCST904687510.65
4321Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T144ECGU0001440.65
4322LY6D/PLA2G10 ratioGCST903153450.65
4323APPL2 levelsGCST904683430.65
4324Right-hemisphere limbic network to hippocampus white-matter structural connectivityGCST903028310.65
4325DTI autoptx L1 cst r tractGCST903851480.65
4326Right-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivityGCST903027800.65
4327Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST906685050.65
4328SUMF2 levelsGCST904707840.65
4329Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARBUKBB000006900.65
4330NCR1 levelsGCST900901530.65
4331Holdemania abundance in stoolGCST900324320.65
4332THBS2 levelsGCST904708540.65
4333Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T361ECGA0003610.65
4334MICB or MICA levelsGCST904699050.65
4335Right-hemisphere somatomotor network to right-hemisphere control network white-matter structural connectivityGCST903027920.65
4336DTI TBSS FA Retrolenticular part of internal capsule RGCST903844000.65
4337LGALS1 levelsGCST904697590.65
4338Atrial fibrillation and flutter (PheCode 427.2)GCST900439770.65
4339aparc-DKTatlas rh volume lateraloccipitalGCST900029020.65
4340Coffee type: Instant coffee (UKB data field 1508_2)GCST900418020.65
4341CAG-177 abundance in stoolGCST900322610.65
4342aparc-a2009s rh thickness G-temporal-middleGCST900037140.65
4343Bariatric surgery (PheCode 539)GCST904760550.64
4344wg rh intensity-contrast precentralGCST900038500.64
4345NH4_C22:4 Cholesteryl ester levels in chronic kidney diseaseGCST902572270.64
4346ThalamNuclei rh volume PuIGCST900027380.64
4347HAVCR1 levelsGCST904694310.64
4348T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 116)GCST903209350.64
4349Right-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST903027990.64
4350aseg global volume SupraTentorialGCST900025950.64
4351PLXNA4/SPRY2 ratioGCST903156870.64
4352DAPP1/PMVK ratioGCST903143960.64
4353PSTPIP2 levelsGCST904703660.64
4354NIT2 levelsGCST904700510.64
4355CTSH levelsGCST900885010.64
4356HS6ST2 levelsGCST904694800.64
4357Succinylcarnitine levelsGCST902438740.64
4358Heart failure and bmi 25plusFING000006030.64
4359aparc-Desikan lh area TotalSurfaceGCST900030730.64
4360IDP dMRI ProbtrackX OD fmiGCST900044610.64
4361Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)GCST902695550.63
4362NPTXR levelsGCST904700800.63
4363KIRREL2 levelsGCST904696900.63
4364Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T141ECGU0001410.63
4365SPRY2 levelsGCST904707380.63
4366EDAR/PSRC1 ratioGCST903145840.63
4367Smoking status, ever vs never | Other measurementUKBB000007820.63
4368Gastritis and duodenitis | Diseases of oesophagus, stomach and duodenumUKBB000002780.63
4369Internal derangement of knee | injuries & poisoningsUKBB000003680.63
4370T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92)GCST903206550.63
4371Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T419ECGU0004190.63
4372FCRL3 levelsGCST904692070.63
4373ALB levelsGCST902786160.63
4374Total testosterone levelsGCST900121130.63
4375FOXO3 levelsGCST904692660.63
4376Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T15ECGA0000150.63
4377Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levelsGCST902001180.62
4378IDP T1 FAST ROIs R cerebellum crus IIGCST900025740.62
4379DAG1/DKK1 ratioGCST903143730.62
4380CIRBP levelsGCST904687560.62
4381Oral glucose tolerance test-2hGCST905664230.62
4382aparc-Desikan rh volume lateraloccipitalGCST900028110.62
4383Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T71ECGU0000710.62
4384Brussel sprout likingGCST900947140.62
4385IDP dMRI ProbtrackX MD cst rGCST900042280.61
4386Leisure/social activities - Other group activity | Social supportUKBB000004000.61
4387Glomerular filtration rate (cystatin C)GCST0033750.61
4388DTI autoptx L2 str l tractGCST903851890.61
4389IDP dMRI TBSS L3 Genu of corpus callosumGCST900041730.61
4390HyperthyroidismGCST904681360.61
4391aparc-a2009s rh area S-subparietalGCST900034410.61
4392GNPDA2 levelsGCST904693740.61
4393COL28A1 levelsGCST904688150.61
4394Peripheral artery diseaseGCST900186700.61
4395Microalbumin urineGCST902786390.61
4396HNRNPK/VASH1 ratioGCST903150710.61
4397CDC42BPB levelsGCST904686660.61
4398ASGR1/DCBLD2 ratioGCST903133640.61
4399Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T364ECGA0003640.61
4400Left-hemisphere dorsal attention network to left-hemisphere default mode network white-matter structural connectivityGCST903026930.61
4401GUSB levelsGCST904694210.61
4402IDP dMRI TBSS ICVF Medial lemniscus RGCST900043350.61
4403aparc-a2009s lh area S-postcentralGCST900033630.61
4404GAST levelsGCST904693070.60
4405Principal component-derived dietary pattern 11GCST901330160.60
4406DTI autoptx FA atr l tractGCST903851140.60
4407Abnormal results of function study of thyro (PheCode 246.7)GCST904756540.60
4408DTI TBSS MD Posterior thalamic radiation RGCST903846000.60
4409CDSN/WFDC12 ratioGCST903139990.60
4410Volume of right cortico-amygdaloid transition areaGCST904749110.60
4411Pancreas fatGCST900166750.60
4412GGH/INHBC ratioGCST903149280.60
4413PCDHB15 levelsGCST904701730.60
4414EDAR/TXNDC5 ratioGCST903145930.60
4415LYN/SIRT2 ratioGCST903153490.60
4416T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64)GCST903206270.60
4417IDP dMRI ProbtrackX ISOVF atr lGCST900045270.60
4418Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T128ECGU0001280.60
4419IDP dMRI TBSS FA Posterior limb of internal capsule LGCST900038960.60
4420MPHOSPH8 levelsGCST904699340.60
4421APP/VEGFC ratioGCST903133330.60
4422DPEP1 levelsGCST900903020.60
4423Volume of right lateral nucleusGCST904750340.60
4424DAB2/FKBP5 ratioGCST903143630.59
4425CTSV levelsGCST904689170.59
4426total creatine kinase (minimum, inv-norm transformed)GCST904764160.59
4427DTI TBSS MD Retrolenticular part of internal capsule LGCST903845930.59
4428Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T416ECGU0004160.59
4429Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levelsGCST902000330.59
4430ECM1 levelsGCST904690650.59
4431eGFR in diabetes mellitus (loose) (minimal adjustment)GCST906247830.59
4432Creatinine levelsGCST904972360.59
4433DFFA levelsGCST904689870.59
4434Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T365ECGA0003650.59
4435IDP dMRI ProbtrackX ICVF ifo rGCST900043880.59
4436aseg global volume BrainSegGCST900025900.59
4437DNAJB14 levelsGCST902409520.59
4438Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T69ECGU0000690.59
4439IDP dMRI TBSS L2 Posterior corona radiata LGCST900041500.59
4440NTN1 levelsGCST902420470.59
4441CBLIF levelsGCST904685520.59
4442KLK8 levelsGCST904223160.59
4443DTI TBSS L2 External capsule RGCST903845080.59
4444Duodenal ulcerGCST902709280.59
4445Suicide or other Intentional self-harmFING000013450.59
4446FIS1/PDGFB ratioGCST903148300.58
4447Operation code - bilateral oophorectomy | OperationsUKBB000005500.58
4448NPDC1/TAFA5 ratioGCST903155500.58
4449IDP dMRI TBSS L1 Inferior cerebellar peduncle LGCST900040860.58
4450CTF1/ITGB1BP2 ratioGCST903143050.58
4451HMOX2 levelsGCST904694660.58
4452BLOC1S3 levelsGCST904684500.58
4453CXCL5/PPIB ratioGCST903143520.58
4454TNN levelsGCST904709270.58
4455Hypertensive Heart DiseaseFING000006390.58
4456Gout (PheCode 274.1)GCST904763790.58
4457CD200 levelsGCST904686060.58
4458Alcohol use and misuse (confirmatory factor analysis Factor 22)GCST903093560.58
4459EDAR/ENO2 ratioGCST903145740.58
4460CLEC14A levelsGCST904687660.58
4461IDP dMRI ProbtrackX L2 ptr rGCST900042930.57
4462DBNL/EDAR ratioGCST903144160.57
4463NECTIN2/NPDC1 ratioGCST903155280.57
4464Asthma | respiratoryUKBB000000540.57
4465Membranous nephropathyGCST0100060.57
44665-oxoproline levelsGCST902434370.57
4467DYNLL1 levelsGCST902409840.57
4468S100A11 levelsGCST904705120.57
4469SH3GLB2 levelsGCST904706210.57
4470wg lh intensity-contrast precuneusGCST900038160.57
4471IDP dMRI TBSS ICVF Splenium of corpus callosumGCST900043310.57
4472KCTD5 levelsGCST904696700.57
4473ITGB1BP2/MITD1 ratioGCST903152140.57
4474CAG-776 abundance in stoolGCST900322970.57
4475CNTNAP2/DPP10 ratioGCST903141670.57
4476Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T387ECGA0003870.57
4477Ulcerative colitis (PheCode 555.2)GCST900441550.57
4478Asthma | Chronic lower respiratory diseasesUKBB000000530.56
4479PRR15 levelsGCST904247900.56
4480X-11786--methylcysteine levelsGCST902436540.56
4481Right ventricular stroke volumeGCST902681220.56
4482Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T4ECGA0000040.56
4483FUT8/TNFSF14 ratioGCST903148950.56
4484X-04499--3,4-dihydroxybutyrate levelsGCST902434970.56
4485HippSubfield lh volume CA4-bodyGCST900026830.56
4486Selective deficiency of immunoglobulin G [IgG] subclassesFING000012880.56
4487COLEC12/LTBR ratioGCST903141820.56
4488Chronic obstructive pulmonary disease x current smoker interaction (main effect)GCST900165910.56
4489DNAJB14 levelsGCST904272350.56
4490SFTPA1 levelsGCST904706120.56
4491FLT3LG levelsGCST902747910.56
4492APOA4 levelsGCST904683330.56
4493ALKBH3 levelsGCST906190950.56
4494CCER2 levelsGCST904685630.56
4495MVK levelsGCST904699670.56
4496CPB1 levelsGCST904688390.56
4497Headaches for 3+ months | PainUKBB000003070.56
4498Retention of urine (PheCode 599.2)GCST904761500.56
4499Non-seminoma of testis, excluding all cancers (controls excluding all cancers)FING000008740.56
4500C7 levelsGCST904685020.56
4501PTPRN2 levelsGCST904703850.55
4502EDAR/F11R ratioGCST903145760.55
4503CD300LG/DSG2 ratioGCST903138020.55
4504Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T367ECGA0003670.55
4505Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)FING000007710.55
4506T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92)GCST903209110.55
4507Atrial fibrillation/atrial flutterGCST900185760.55
4508Acute peritonitisFING000000280.55
4509LEFTY2 levelsGCST904697520.55
4510Type 2 diabetes (PheCode 250.2)GCST904756670.55
4511MRPL33 levelsGCST906179860.55
4512Other eye problems | EyesightUKBB000006100.55
4513F-chocolate/coffee liking (derived food-liking factor)GCST900947350.55
4514Active to sedentary transition probabilityGCST900614290.55
4515Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T386ECGA0003860.55
4516Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T163ECGU0001630.55
4517EGFLAM levelsGCST904690840.55
4518Left-hemisphere default mode network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027620.55
4519PER3 levelsGCST904702100.55
4520VAV3 levelsGCST904710300.55
4521CNTN3/NCS1 ratioGCST903141650.55
4522PPM1F levelsGCST904702970.55
4523Chronic obstructive pulmonary disease in non-current smokersGCST900165940.55
4524F10 levelsGCST904691630.54
4525Phospholipids in large HDL (UKB data field 23560)GCST902696570.54
4526Types of transport used (excluding work) - Walk | Physical activityUKBB000008790.54
4527Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T421ECGU0004210.54
4528Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T390ECGA0003900.54
4529CSNK1D levelsGCST904688880.54
4530IPCEF1/TBCB ratioGCST903151870.54
4531Volume of left basal nucleusGCST904748770.54
4532Volume of left lateral nucleusGCST904749700.54
4533GC levelsGCST901625640.54
4534AHCY/FABP5 ratioGCST903132080.54
4535EDAR/ERBIN ratioGCST903145750.54
4536IDP dMRI ProbtrackX L2 cgc lGCST900042770.53
4537SIRT1 levelsGCST904706410.53
4538RUVBL1 levelsGCST904705090.53
4539MCAM/NCAM1 ratioGCST903154080.53
4540Acute pancreatitisGCST900185690.53
4541CX3CL1 levelsGCST904689210.53
4542COMP/THBS4 ratioGCST903141930.53
4543CHI3L1/HSPG2 ratioGCST903140430.53
4544ROBO1/SPON1 ratioGCST903157830.53
4545Pain type(s) experienced in last month - Headache | PainUKBB000006270.53
4546Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T468ECGU0004680.53
4547Hippocampal subfield left CA3 volume (body)GCST902679400.53
4548Left ventricular end diastole anterospetal wall thicknessGCST902785190.53
4549LY75 levelsGCST904698220.53
4550Tea without sugar likingGCST900948580.53
4551EDAR/LAT2 ratioGCST903145820.53
4552HPGDS levelsGCST904694720.53
4553CST3/TAFA5 ratioGCST903142980.53
4554CRNN levelsGCST902778900.53
4555Urine 5-acetylamino-6-amino-3-methyluracil levels in chronic kidney diseaseGCST902646740.53
4556ENPP6 levelsGCST904691170.53
4557Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T142ECGU0001420.53
4558Aspartate aminotransferase levelsGCST902786180.53
4559rfMRI connectivity ICA-features 6GCST900063440.53
4560aparc-a2009s lh area S-oc-middle+LunatusGCST900033530.53
4561Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T115ECGU0001150.53
4562IL1R2/MEGF9 ratioGCST903151590.53
4563TMSB10 levelsGCST904708940.53
4564CPA1 levelsGCST904688360.52
4565Total cholesterol response to statins (relative logarithmic difference)GCST904556080.52
4566EDAR/PRDX5 ratioGCST903145830.52
4567IDP dMRI ProbtrackX L1 cgh lGCST900042520.52
4568Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T165ECGU0001650.52
4569X-12216 levelsGCST902004830.52
4570Ovarian cystFING000011320.52
4571All anxiety disordersFING000000590.52
4572SnoringGCST0097610.52
4573Triacylglycerol_51:4_[M+NH4]1+ levelsGCST900604910.52
4574T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109)GCST903209280.52
4575ARHGAP45 levelsGCST904683550.52
4576Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T134ECGU0001340.52
4577CLUL1 levelsGCST904687920.52
4578Medication for pain relief, constipation, heartburn - Aspirin | MedicationUKBB000004540.52
4579Bioavailable testosterone levelsGCST900121040.52
4580Docosahexaenoic acid to total fatty acids percentageGCST905022850.52
4581Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T391ECGA0003910.52
4582PCBP2 levelsGCST904701670.52
4583aparc-a2009s lh volume G-front-inf-TriangulGCST900029380.52
4584Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T369ECGA0003690.51
4585ICD10 O00: Ectopic pregnancyGCST904542270.51
4586Ectopic pregnancyGCST902728830.51
4587wg rh intensity-contrast superiorparietalGCST900038550.51
4588CD55 levelsGCST904686370.51
4589SSH3 levelsGCST904707490.51
4590Acne (PheCode 706.1)GCST904762110.51
4591Heart failure, strictFING000006060.51
4592Left-hemisphere salience/ventral attention network to left-hemisphere control network white-matter structural connectivityGCST903027100.51
4593SLC51B levelsGCST904706640.51
4594VWA1 levelsGCST904710610.51
4595Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T57ECGU0000570.51
4596triglyceride (minimum, inv-norm transformed)GCST904764370.51
4597CCL13/CCL17 ratioGCST903136740.51
4598Moderate to vigorous physical activity levelsGCST0060970.51
4599SRP14 levelsGCST904707420.51
4600Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T64ECGA0000640.51
4601wg lh intensity-contrast posteriorcingulateGCST900038140.51
4602SNAP23/TXLNA ratioGCST903158570.51
4603CST3/TIMP1 ratioGCST903143000.51
4604FLT4/KDR ratioGCST903148610.51
4605IDP dMRI TBSS ICVF Superior corona radiata LGCST900043520.51
4606EczemaGCST904681260.51
4607UBXN1 levelsGCST904710040.51
4608ICA1 levelsGCST904694970.50
4609Pork consumptionGCST901329990.50
4610TACSTD2 levelsGCST904707980.50
4611CDKN2D/MANF ratioGCST903139890.50
4612REST UKBBICA NODEamps25 0021GCST903855040.50
4613CRELD2/HYOU1 ratioGCST903142550.50
4614Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T373ECGA0003730.50
4615Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T145ECGU0001450.50
4616BCAT1 levelsGCST904684270.50
4617Other venous embolism and thrombosis (PheCode 452)GCST904760070.50
4618CD63/EDAR ratioGCST903138640.50
4619PBLD levelsGCST904701630.50
4620FrecklesGCST0060910.50
4621AGRP levelsGCST900120630.50
4622Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levelsGCST902001450.50
4623HEXIM1/IKBKG ratioGCST903150450.50
4624Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T25ECGA0000250.50
4625KIAA0319 levelsGCST904696760.50
4626MIF/SUSD2 ratioGCST903154520.50
4627IDP dMRI TBSS L2 Anterior limb of internal capsule LGCST900041400.50
4628Temporomandibular joint disorders, including avohilmoFING000013550.50
4629FKBP14 levelsGCST904692410.50
4630MCFD2 levelsGCST904698730.50
4631AGT levelsGCST904682570.50
4632PHACTR2 levelsGCST904702240.50
4633MMP1/MMP3 ratioGCST903154610.50
4634Blood cell traits latent factor 14 (red cell)GCST905592560.50
4635Tonsillectomy and adenotomyFING000013670.50
4636Left-hemisphere control network to left-hemisphere control network white-matter structural connectivityGCST903027430.49
4637IDP dMRI TBSS ICVF Anterior limb of internal capsule RGCST900043430.49
4638Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T220ECGA0002200.49
4639Other disorders of intestine | digestiveUKBB000006080.49
4640DCBLD2/PLA2G15 ratioGCST903144280.49
4641GP1BA levelsGCST904693800.49
4642Prescriptions - albuterol | beta2-agonist,bronchodilator,asthmaUKBB000006580.49
4643Prescriptions - beta2-agonist|bronchodilator|asthmaUKBB000006700.49
4644ALPP/LAMP3 ratioGCST903132490.49
4645Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T368ECGA0003680.49
4646Enteropathic arthropathiesFING000005080.49
4647ALCAM/IL1RL2 ratioGCST903132380.49
4648CAG-776 sp000438195 abundance in stoolGCST900322960.49
4649WASF1 levelsGCST904710670.49
4650PLXNA4/VASH1 ratioGCST903156910.49
4651Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T460ECGA0004600.49
4652LMOD1 levelsGCST904697830.49
4653IGFBP6/PTGDS ratioGCST903151370.48
4654TDRKH/TST ratioGCST903159130.48
4655Hypotaurine levelsGCST902003790.48
4656CCL21 levelsGCST904685730.48
4657HEXIM1/NT5C3A ratioGCST903150480.48
4658aparc-pial rh area lateraloccipitalGCST900031840.48
4659ICAM2 levelsGCST904694990.48
4660PCDH17/THBD ratioGCST903156070.48
4661HippSubfield rh volume GC-ML-DG-bodyGCST900027030.48
4662Dizziness and giddiness (Light-headedness and vertigo) (PheCode 386.9)GCST904759080.48
4663DPP6/NRCAM ratioGCST903145420.48
4664ANXA3/BID ratioGCST903132790.48
4665T1 FreeSurfer a2009s rh G cuneus areaGCST903849000.48
4666BCAM/CDH5 ratioGCST903134690.48
4667ANXA10 levelsGCST904683140.48
4668CC2D1A levelsGCST904685570.48
4669TGFBR2 levelsGCST904708470.48
4670Anaphylactic shock due to adverse effect of correct drug or medication properly administeredFING000000840.48
4671RAB11FIP3 levelsGCST904704040.48
4672Haemoglobin concentration | Blood countUKBB000002930.48
4673Left-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivityGCST903027180.48
4674PPL levelsGCST904702940.48
4675Major depressive disorder (probable)GCST0059040.48
4676Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T422ECGU0004220.48
4677rfMRI connectivity (ICA100 edge 619)GCST900054720.48
4678Multiple system atrophyGCST904069250.48
4679FLT1/VEGFA ratioGCST903148580.48
4680Left ventricular end diastolic volume (indexed to body surface area)GCST904352580.48
4681TNFSF10 levelsGCST902748430.48
4682CIAPIN1/SNX9 ratioGCST903140680.47
4683VEGFC/ZBTB16 ratioGCST903159460.47
4684aparc-DKTatlas rh volume parstriangularisGCST900029110.47
4685FAM13A levelsGCST904691810.47
4686Operative procedures - Injection of therapeutic substance into joint | Summary OperationsUKBB000005820.47
4687Hearing difficulty/problems | HearingUKBB000003100.47
4688T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45)GCST903206080.47
4689Breast cancerGCST0049880.47
4690IDP dMRI TBSS ICVF Inferior cerebellar peduncle RGCST900043370.47
4691EpiscleritisFING000005130.47
4692IDP dMRI TBSS ICVF Fornix cres+Stria terminalis RGCST900043650.47
4693CDH5/PCDH17 ratioGCST903139580.47
4694HippSubfield rh volume subiculum-bodyGCST900026910.47
4695Succinoyltaurine levelsGCST902002350.47
4696Operative procedures - Closed reduction of fracture of bone and fixation using nail or screw | Summary OperationsUKBB000005750.47
4697Osteoarthrosis NOS (PheCode 740.9)GCST904762560.47
4698Treatment or medication use - rosuvastatin (UKB data field 20003_1141192410)GCST900425390.47
46991-arachidonoylglycerophosphocholine levelsGCST902436740.47
4700WFDC1 levelsGCST904710740.47
4701aseg lh intensity PutamenGCST900037700.47
4702Breast cancerGCST0100980.47
4703Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T372ECGA0003720.47
4704PTPN6/SNAP23 ratioGCST903157470.47
4705Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T388ECGA0003880.47
4706IDP dMRI ProbtrackX ICVF str lGCST900043980.47
4707Hearing difficulty/problems | HearingUKBB000003110.47
4708Total lipids in HDL (UKB data field 23426)GCST902695230.47
4709HEXIM1/NUB1 ratioGCST903150490.47
4710CCL5/CXCL3 ratioGCST903137000.47
4711total creatine kinase (mean, inv-norm transformed)GCST904764130.47
4712Creatinine levelsGCST902786240.46
4713Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T389ECGA0003890.46
4714PLXNB2 levelsGCST902422990.46
4715GBA1 levelsGCST904232620.46
4716CTSO/IGF2R ratioGCST903143170.46
4717Free androgen indexGCST902398230.46
4718EIF4G1 levelsGCST904690970.46
4719Disorders of eyelid, lacrimal system and orbitFING000004390.46
4720Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T371ECGA0003710.46
4721Diacylglycerol (18:0_18:1) levelsGCST900247140.46
4722SERPINI2 levelsGCST904706030.46
4723AP3B1 levelsGCST904683250.46
4724IDP T1 FAST ROIs R cerebellum VGCST900025650.46
4725BA-exvivo rh area BA6GCST900032270.46
4726Plasma N-acetylhistidine levels in chronic kidney diseaseGCST902655760.46
4727DTI autoptx MD atr r tractGCST903852230.46
4728LCN15 levelsGCST904697460.46
4729aseg global volume BrainSegNotVentSurfGCST900025920.46
4730CACNB3 levelsGCST904685230.46
4731Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T366ECGA0003660.46
4732NT5C3A levelsGCST904700910.46
4733ICD10 N83.0, N83.1, N83.2: Ovarian cyst, including follicular cyst, corpus luteum cyst, and other/unspecified ovarian cystGCST904542150.46
4734GLOD4 levelsGCST904693590.46
4735Sleep apnoea, including avohilmoFING000013100.46
4736POSTN levelsGCST904702880.46
4737Mean volume of bilateral amygdalaGCST904749920.46
4738IDP dMRI ProbtrackX ICVF atr lGCST900043770.45
4739Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T160ECGU0001600.45
4740APOE levelsGCST904683380.45
4741IDP T1 FAST ROIs R subcallosal cortexGCST900025040.45
4742NUMB levelsGCST904701080.45
4743ADD1 levelsGCST904682330.45
4744GPC1 levelsGCST904693860.45
4745IDP SWI T2star left caudateGCST900038650.45
4746Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T370ECGA0003700.45
4747Gestational [pregnancy-induced] oedema and proteinuria without hypertensionFING000005720.45
4748ANGPT1/MPIG6B ratioGCST903132650.45
4749CHGA levelsGCST902406990.45
4750Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T46ECGA0000460.45
4751Chronic obstructive pulmonary disease x ever smoker interaction (main effect)GCST900165860.45
4752OtosclerosisGCST901295750.45
4753PEAR1/SCARF1 ratioGCST903156420.45
4754Blood cell traits latent factor 13 (red cell)GCST905592550.45
4755Cancer code, self-reported: breast cancer (UKB data field 20001_1002)GCST900418860.45
4756Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T113ECGU0001130.45
4757PRTFDC1 levelsGCST904703460.45
4758NAGPA levelsGCST902420040.45
4759ZBTB17 levelsGCST904710960.45
4760CEACAM8/RNASE3 ratioGCST903140040.45
4761BTN2A1/SMOC2 ratioGCST903135490.45
4762Heart rate variability traits (RMSSD)GCST0047330.45
4763GIT1 levelsGCST904693510.45
4764AsthmaGCST900143250.45
4765Medication for pain relief, constipation, heartburn - Ibuprofen (e.g. Nurofen) | MedicationUKBB000004550.45
4766IDP dMRI TBSS FA Superior cerebellar peduncle LGCST900038900.44
4767Urinary calculus | genitourinaryUKBB000008860.44
4768Cardiac pacemaker in situ (PheCode 426.91)GCST904759600.44
4769Estimated glomerular filtration rate (creatinine)GCST901036340.44
4770Low hand grip strength (60 years and older) (EWGSOP)GCST900075280.44
4771MAPKAPK2 levelsGCST904698580.44
4772EDAR/SPARC ratioGCST903145880.44
4773Disorders of vestibular function (Vertigo)FING000004640.44
4774Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T374ECGA0003740.44
4775Urate levels (UKB data field 30880)GCST904681070.44
4776PLEKHO1 levelsGCST904702560.44
4777TMED8 levelsGCST904708850.44
4778MYOM3 levelsGCST904699860.44
4779Docosahexaenoic acid levelsGCST905022590.44
4780Paternal history of Alzheimer's diseaseGCST0059200.44
4781IDP dMRI TBSS ICVF Anterior corona radiata RGCST900043490.44
4782ICOSLG levelsGCST904695030.44
4783aparc-pial rh area caudalmiddlefrontalGCST900031770.44
4784P4HB levelsGCST904701400.44
4785Ceramide (d18:2/22:0) levelsGCST900240540.44
4786Phospholipids in HDL (UKB data field 23414)GCST902695110.44
4787NUDC levelsGCST904701020.44
4788CCL25 levelsGCST902747680.44
4789Takes medication for skin cancer?GCST904751900.44
4790GAL levelsGCST904693000.44
4791Benign mammary dysplasiaFING000001510.43
4792IDP dMRI TBSS L1 Sagittal stratum RGCST900041050.43
4793Other anxiety disordersFING000009600.43
4794KLK4 levelsGCST904697040.43
4795Treatment/medication code - perindopril | MedicationsUKBB000008540.43
4796FOXO3/SH2B3 ratioGCST903148810.43
4797SERPINB9 levelsGCST904705930.43
4798ITGB5 levelsGCST904696450.43
4799Calculus of kidney | genitourinaryUKBB000001150.43
4800DTI TBSS L2 Sagittal stratum RGCST903845060.43
4801Lysoalkylphosphatidylcholine (O-20:0) levelsGCST900254320.43
4802aparc-pial rh area inferiorparietalGCST900031810.43
4803NIT1 levelsGCST904700500.43
4804Left-hemisphere dorsal attention network to right-hemisphere limbic network white-matter structural connectivityGCST903026980.43
4805estimated glomerular filtration rate (eGFR, maximum, inv-norm transformed)GCST904752800.43
4806aparc-pial lh area TotalSurfaceGCST900031410.42
4807LHPP levelsGCST904697680.42
4808TAB2 levelsGCST904707960.42
4809Excessive scarringGCST904833680.42
4810SERPINA3 levelsGCST904705830.42
4811SMAD3 levelsGCST904706770.42
4812BSG/CKAP4 ratioGCST903135310.42
4813Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T375ECGA0003750.42
4814HDL cholesterol levels (UKB data field 30760)GCST904680750.42
4815SIRT2 levelsGCST904706420.42
4816Allergic rhinitisGCST900860420.42
4817PEAR1/SPINT2 ratioGCST903156440.42
4818CCN3 levelsGCST902424920.42
4819PMVK levelsGCST904702720.42
4820Hemoglobin concentrationGCST900023100.42
4821MSR1/TNFRSF21 ratioGCST903154940.42
4822Weight (minimum, inv-normal transformed)GCST904764660.42
4823CST6/NECTIN4 ratioGCST903143030.42
4824SLMAP levelsGCST904706730.42
4825Neonatal jaundice (paternal effect)GCST904351470.42
4826Nonalcoholic fatty liver diseaseGCST900547820.42
4827Blood cell traits latent factor 5 (platelet)GCST905592470.42
4828Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T162ECGU0001620.42
4829Lysophosphatidylcholine (26:0) [sn1] levelsGCST900241880.42
4830aparc-pial lh area parstriangularisGCST900031600.42
4831MMP8 levelsGCST904699220.42
4832SCARF1/TNFRSF14 ratioGCST903158120.42
4833GP1BB levelsGCST904693810.42
4834HematocritGCST900023040.42
4835HematocritGCST0046040.42
4836Phlebitis and thrombophlebitis (PheCode 451)GCST904760030.42
4837Other diseases of the digestive systemFING000010100.41
4838Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229ECGU0002290.41
4839Spread type: Any oil based spread vs never use spread (UKB data field 1428)GCST901329490.41
4840Diabetes mellitus (PheCode 250)GCST904756580.41
4841FOLH1 levelsGCST904692580.41
4842Other disorders of circulatory system | circulatory systemUKBB000006070.41
4843aparc-Desikan rh area precentralGCST900031300.41
4844Red meat likingGCST900948190.41
4845IDP dMRI TBSS FA Posterior thalamic radiation LGCST900039060.41
4846CAG-273 sp003507395 abundance in stoolGCST900322690.41
4847GM2A levelsGCST904693650.41
48481-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levelsGCST902006920.41
4849VTI1A levelsGCST904710600.41
4850Facial pigmentation measurement (polar light)GCST900022840.41
4851Retinal thickness (functional principal component 5)GCST904557250.41
4852Volume of right basal nucleusGCST904749100.41
4853CHL1 levelsGCST904687450.41
4854DOK2/LACTB2 ratioGCST903145320.41
4855Platelet count during third trimester of pregnancyGCST903022260.41
4856Docosahexaenoic acid to total fatty acids percentageGCST905019910.41
4857CD69/TXNDC5 ratioGCST903138890.41
4858Fracture of radius and ulna (PheCode 803.2)GCST904762800.41
4859PRAP1 levelsGCST904703120.41
4860Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T439ECGU0004390.41
4861CXCL11 levelsGCST902747810.41
4862PDAP1 levelsGCST904701790.41
4863CHRDL1/SMOC2 ratioGCST903140620.41
4864VPS4B levelsGCST904710470.41
4865T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65)GCST903208840.41
4866HEXIM1 levelsGCST904694470.41
4867N-formylanthranilic acid levelsGCST901999600.41
4868GLA levelsGCST904693540.41
4869Seminoma of testis, excluding all cancers (controls excluding all cancers)FING000012890.41
4870Type 1 diabetesGCST900005290.41
4871PCDH1 levelsGCST904701700.41
4872BMP6/SPINT2 ratioGCST903135290.41
4873IDP T1 FAST ROIs V cerebellum crus IIGCST900025730.40
4874Left-hemisphere control network to hippocampus white-matter structural connectivityGCST903027560.40
4875Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T109ECGU0001090.40
4876PLXNB3 levelsGCST904702670.40
4877VSIG10 levelsGCST904710500.40
4878GRN levelsGCST904694040.40
4879DKK1/MGLL ratioGCST903144730.40
4880Deep vein thrombosis [DVT] (PheCode 452.2)GCST904760100.40
4881KYNU levelsGCST904697220.40
4882MESD/NCK2 ratioGCST903154210.40
4883aparc-a2009s rh volume S-collat-transv-antGCST900030480.40
4884DTI TBSS L2 Anterior limb of internal capsule RGCST903844920.40
4885DOK1 levelsGCST904690280.40
4886Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T24ECGA0000240.40
4887SERPINA12 levelsGCST904705810.40
4888Frequency of tenseness / restlessness in last 2 weeks | Mental healthUKBB000002670.40
4889MPI/TACC3 ratioGCST903154910.40
4890CD40/TIMP3 ratioGCST903138290.40
4891PCSK9 levelsGCST904701770.40
4892GP2 levelsGCST904693820.40
4893PneumoniaGCST900186810.40
4894BA-exvivo lh thickness MTGCST900035240.40
4895CD209/ITGAV ratioGCST903137530.40
4896Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T443ECGU0004430.40
4897Medication for pain relief, constipation, heartburn - Paracetamol | MedicationUKBB000004590.40
4898MINK1 levelsGCST904699090.40
4899Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T376ECGA0003760.39
4900Trunk fat mass | Impedance measuresUKBB000008630.39
4901Childhood sunburn occasions | Sun exposureUKBB000001300.39
4902Methods of admission to hospital (recoded) - Elective admission: Planned | Summary AdministrationUKBB000004620.39
4903Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025700.39
4904PPP3R1 levelsGCST904703070.39
4905DTNB levelsGCST904690460.39
4906IDP T1 FAST ROIs L cerebellum crus IGCST900025690.39
4907Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T378ECGA0003780.39
4908Total Phosphatidylethanolamine levelsGCST900252070.39
4909UNC5D levelsGCST904710100.39
4910Acute osteomyelitis (PheCode 710.11)GCST904762220.39
4911GLT25D1 levelsGCST904264210.39
4912Chronic airway obstruction | respiratoryUKBB000001350.39
4913Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T10ECGA0000100.39
4914Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T385ECGA0003850.39
4915Breast cancer (estrogen-receptor negative)GCST0050760.39
4916Loneliness (weighted GWA)GCST902672890.39
4917CALCOCO1 levelsGCST904685300.39
4918IDP dMRI TBSS ICVF Anterior corona radiata LGCST900043500.39
4919F9 levelsGCST904691720.39
4920Chronic obstructive pulmonary disease in never smokersGCST900165890.39
4921CLEC1B/NSFL1C ratioGCST903140990.39
4922PDGFRA levelsGCST904210930.39
4923IDP dMRI TBSS ICVF Sagittal stratum RGCST900043570.39
4924HematocritGCST900023830.39
4925CRKL/MGLL ratioGCST903142700.39
4926aparc-a2009s rh area G+S-occipital-infGCST900033720.38
4927SMTN levelsGCST904706890.38
49284-acetamidobutanoate levelsGCST902434400.38
4929SPART levelsGCST904707190.38
4930Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB000001670.38
4931Gastric cancerGCST900186290.38
4932HippSubfield lh volume Hippocampal-tailGCST900026680.38
4933DTI TBSS MD Posterior corona radiata RGCST903845980.38
4934wg lh intensity-contrast inferiorparietalGCST900037990.38
4935T1 FreeSurfer aseg Left-PutamenGCST903841450.38
4936ATF6 levelsGCST902408160.38
4937rfMRI connectivity (ICA100 edge 614)GCST900054670.38
4938ArthropathiesFING000001070.38
4939HSPB1 levelsGCST904694890.38
4940Left-hemisphere control network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027480.38
4941XIAP levelsGCST904710830.38
4942High density lipoprotein cholesterol levelsGCST902396510.38
4943Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T228ECGA0002280.38
4944MEPE/SOST ratioGCST903154200.38
4945Sedentary behavior at workGCST901043450.38
4946Cholesteryl ester_16:0_[M+NH4]1+ levelsGCST900602110.38
4947Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T437ECGU0004370.37
4948GPC1/ITGB6 ratioGCST903149770.37
4949PDLIM7/PLA2G4A ratioGCST903156370.37
4950Sebaceous cyst (PheCode 706.2)GCST904762130.37
4951Omega-3 fatty acids to total fatty acids percentageGCST905020900.37
4952Platelet countGCST900023580.37
4953Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T241ECGU0002410.37
4954IFNGR2 levelsGCST904695140.37
4955NFE2 levelsGCST904700350.37
4956F-healthy breakfast food liking (derived food-liking factor)GCST900947800.37
4957aparc-DKTatlas rh area parstriangularisGCST900032830.37
4958Retention of urineFING000012570.37
4959MARS1 levelsGCST904698620.37
4960Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T465ECGU0004650.37
4961T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119)GCST903206820.37
4962Myristoyl dihydrosphingomyelin (d18:0/14:0) levelsGCST902000490.37
4963DNAJA2/PLXNA4 ratioGCST903145040.37
4964IDP dMRI ProbtrackX L3 fmaGCST900043100.37
4965Triacylglycerol_54:7_[M+NH4]1+ levelsGCST900605360.37
4966Other dorsopathies, not elsewhere classifiedFING000010410.37
4967Thyroid stimulating hormone levelsGCST903193210.37
4968Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453)GCST902695500.37
4969Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T114ECGU0001140.37
4970PAXX levelsGCST904701610.37
4971IDP dMRI TBSS ICVF Tapetum LGCST900043740.37
4972ADGRE5/GAS6 ratioGCST903131790.37
4973LGALS8/VWF ratioGCST903153220.37
4974ASPSCR1 levelsGCST904683780.37
4975NID1 levelsGCST904700470.37
4976CTSH levelsGCST904689130.37
4977AP1G2 levelsGCST904683230.36
4978MYOC/NOTCH3 ratioGCST903155070.36
4979Isoleucine levels (UKB data field 23465)GCST902695620.36
4980ITGB1BP2/MED18 ratioGCST903152130.36
4981T1 FreeSurfer DKT lh superiortemporal thicknessGCST903842520.36
4982LRP11/NECTIN2 ratioGCST903153290.36
4983S100A12 levelsGCST904705130.36
4984Fracture of lumbar spine and pelvisFING000005560.36
4985TGOLN2 levelsGCST904708500.36
4986HS6ST1/MEGF9 ratioGCST903150810.36
4987Breast cancerGCST904681170.36
4988Medication use (diuretics)GCST900187650.36
4989T1 CAT volume L LeftAccumbensGCST903841080.36
4990PEBP1 levelsGCST904702050.36
4991Takes medication for Diabetes/sugar?GCST904752680.36
4992Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T420ECGU0004200.36
4993Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T63ECGU0000630.36
4994Volume of right lateral nucleusGCST904750360.36
4995aparc-DKTatlas lh area rostralmiddlefrontalGCST900032590.36
4996ArthrosisFING000001110.36
4997DBNL/PDGFB ratioGCST903144220.36
4998Belief that own life is meaningful | Happiness and subjective well-beingUKBB000000900.36
4999Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632)GCST902697290.36
5000CLEC14A/EPHB4 ratioGCST903140790.36